Fujisawa City Hospital is a general hospital in Fujisawa, Kanagawa, Japan. Founded in 1971, the hospital is also a district hospital serving the neighbouring cities of Chigasaki and Kamakura.

During the past decade, Fujisawa City Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fujisawa City Hospital" #1 sponsor was "Bayer" with 5 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Japan Multinational Trial Organization" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fujisawa City Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Sanofi" with 1 trials as a collaborator, "Tokyo Medical and Dental University" with 1 trials as a collaborator and "Yokohama City University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Fujisawa City Hospital" are "Anemia" (3 trials), "Renal Insufficiency, Chronic" (3 trials), "Atrial Fibrillation" (2 trials), "Asthma" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Fujisawa City Hospital" in a lesser frequency.

Most popular intervention types in "Fujisawa City Hospital" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Molidustat (BAY85-3934)" (3 trials), "Darbepoetin alfa" (2 trials), "Placebo" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fujisawa City Hospital" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fujisawa City Hospital". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Fujisawa City Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fujisawa City Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".